Whitney L. Gladney
- Oncology top 1%
- CAR-T cell therapy research 20
- Cancer Immunotherapy and Biomarkers 8
- Pancreatic and Hepatic Oncology Research 3
- Immunology top 2%
- Immunotherapy and Immune Responses 4
- Immune cells in cancer 4
- Cancer Research top 10%
- Biotechnology top 5%
- Biomedical Engineering top 10%
-
- Viral Infectious Diseases and Gene Expression in Insects 3
- CRISPR and Genetic Engineering 2
-
- Virus-based gene therapy research 2
- Co-authors
- Gregory L. BeattyGraham M. TookerKristen B. LongJae W. LeeCarl H. JuneGabriela PlesaSimon F. LaceyJ. Joseph Melenhorst
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United States
In The Last Decade
Whitney L. Gladney
23 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Oncology 1.8k
- Immunology 1.2k
- Cancer Research 207
- Biotechnology 105
- Biomedical Engineering 415
Countries citing papers authored by Whitney L. Gladney
This map shows the geographic impact of Whitney L. Gladney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Whitney L. Gladney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Whitney L. Gladney more than expected).
Fields of papers citing papers by Whitney L. Gladney
This network shows the impact of papers produced by Whitney L. Gladney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Whitney L. Gladney. The network helps show where Whitney L. Gladney may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Whitney L. Gladney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 23 | |
| 3 | 2021 | 24 | |
| 4 | 2021 | 9 | |
| 5 | 2020 | 20 | |
| 6 | 2020 | 2 | |
| 7 | 2020 | 14 | |
| 8 | 2019 | 43 | |
| 9 | 2019 | 12 | |
| 10 | 2019 | 278 | |
| 11 | 2019 | 25 | |
| 12 | Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trialbreakdown → | 2018 | 379 |
| 13 | 2018 | 72 | |
| 14 | 2018 | 9 | |
| 15 | 2017 | 5 | |
| 16 | 2017 | 28 | |
| 17 | 2016 | 190 | |
| 18 | 2016 | 248 | |
| 19 | 2015 | 228 | |
| 20 | Immune Escape Mechanisms as a Guide for Cancer Immunotherapybreakdown → | 2014 | 827 |
About Whitney L. Gladney
Whitney L. Gladney is a scholar working on Oncology, Immunology and Genetics, having authored 24 papers that have together received 2.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (20 papers), Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (4 papers), Immune cells in cancer (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Virus-based gene therapy research (2 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Oncology (1.8k citations), Immunology (1.2k citations) and Cancer Research (207 citations). Whitney L. Gladney has collaborated with scholars based in United States. Frequent co-authors include Gregory L. Beatty, Graham M. Tooker, Kristen B. Long, Jae W. Lee, Carl H. June, Gabriela Plesa, Simon F. Lacey, J. Joseph Melenhorst, Bruce L. Levine and Anne Marie Nelson. Their work appears in journals such as Journal of Clinical Oncology, Blood and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.